How many 8-K filings has Celldex Therapeutics, Inc. filed?

Celldex Therapeutics, Inc. (CLDX) has 13 8-K (Current Event Report) filings on record, spanning Feb 2024 to Apr 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Celldex Therapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Celldex Therapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Celldex Therapeutics, Inc. (CLDX) — 8-K Filings

All 8-K filings from Celldex Therapeutics, Inc.. Browse 13 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (13)

8-K Filing — Apr 2, 2026
8-K Filing — Nov 10, 2025
Celldex Therapeutics Files 8-K — Aug 19, 2025 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on August 19, 2025, reporting other events and financial statements. The company, formerly known as AVANT IMMUNOTHERAPEU
Celldex Therapeutics Files 8-K on Financials — Aug 7, 2025 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing includes financial stateme
Celldex Therapeutics Files 8-K on Director Changes and Shareholder Votes — Jun 6, 2025 Risk: medium
Celldex Therapeutics, Inc. filed an 8-K on June 6, 2025, reporting on several key events. These include the departure of a director, the election of new directo
Celldex Therapeutics Files 8-K on Financials — May 8, 2025 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
Celldex Therapeutics Files 8-K on Financials — Feb 27, 2025 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition, as well as financial statements an
Celldex Therapeutics Files 8-K on Financials — Nov 6, 2024 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on November 6, 2024, reporting on its results of operations and financial condition. The filing includes financial state
Celldex Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
Bristol Myers Squibb to Acquire Celldex Therapeutics for $5.1B — Jun 14, 2024 Risk: medium
Celldex Therapeutics, Inc. announced on June 13, 2024, that it has entered into a definitive agreement to be acquired by Bristol Myers Squibb Company for approx
Celldex Therapeutics Files 8-K on Financials — May 6, 2024 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on May 6, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
Celldex Therapeutics Enters Material Definitive Agreement — Mar 1, 2024 Risk: medium
Celldex Therapeutics, Inc. announced on February 28, 2024, that it entered into a Material Definitive Agreement. The filing also includes other events and finan
Celldex Therapeutics Updates Financial Condition in 8-K Filing — Feb 26, 2024 Risk: low
Celldex Therapeutics, Inc. filed an 8-K on February 26, 2024, to report on its results of operations and financial condition. The filing indicates that the comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX